ATYPICAL CHRONIC MYELOID LEUKEMIA
Clinical trials for ATYPICAL CHRONIC MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL CHRONIC MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for ATYPICAL CHRONIC MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to prevent deadly transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests a new combination of drugs (bendamustine and cyclophosphamide) to prevent graft-versus-host disease and a dangerous immune reaction after a stem cell transplant. It includes 60 adults with high-risk blood cancers like acute myeloid leukemia or myelodysplastic syn…
Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New hope for rare blood cancers: drug combo trial opens
Disease control Recruiting nowThis study tests a new drug called axatilimab, alone or with another drug (azacitidine), for people with advanced blood cancers like MPN, MPN/MDS overlap, or high-risk CMML. Axatilimab is an antibody that blocks a protein on white blood cells to slow cancer growth. The trial aims…
Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated May 19, 2026 11:59 UTC